Jingle Bell Run/Walk for Arthritis in Rockford Nov. 22
The Jingle Bell Run/Walk — the annual holiday-themed fund-raising event to fight and cure arthritis, the nation’s leading cause of disability — will be at Rockford Park District’s Indoor Sportscore Complex (ISC) at 8 a.m., Saturday, Nov. 22.
Voted as one of the nation’s “Most Incredible Themed Races,” the Jingle Bell Run/Walk for Arthritis is an important fund-raising event helping to raise funds to help fight and end arthritis, which affects more than 50 million Americans, or roughly one in five adults.
Contrary to popular belief, arthritis is not an “old person’s” disease. More than 100 different types of arthritis affect people of all ages. In fact, two-thirds of people with arthritis are younger than 65, including 300,000 children.
In Illinois, 2,511,000 people suffer with arthritis. Visit the event website at http://www.arthritis.org/get-involved/jingle-bell-run-walk/.
Meagan Fulmer, chief development officer for the Arthritis Foundation, explained: “When people think of arthritis, they automatically think minor aches and pains, which is far from the truth. Various forms of arthritis can seriously affect joints, muscles, internal organs, eyes, and also claims the lives of nearly 10,000 people each year. This is why the Jingle Bell Run/Walk for Arthritis is so important for this community to raise funds and fight to put an end to this serious disease.”
As the nation’s largest holiday race series, the Arthritis Foundation’s Jingle Bell Run/Walk for Arthritis offers a 5-kilometer timed fun run and a 1-mile walk with other activities for the entire family. To learn more about the Jingle Bell Run/Walk for Arthritis or to register a team, visit www.arthritis.org/JBR.
The Arthritis Foundation (www.arthritis.org) is the largest and most trusted nonprofit organization dedicated to addressing the needs and challenges of those living with arthritis, the nation’s leading cause of disability. Since 1948, the foundation has remained committed to leading groundbreaking research for better treatments and a cure; fighting for patients’ access to affordable and effective health care; and providing trusted information and resources to the more than 50 million adults and 300,000 children living with the disease.
Posted Nov. 19, 2014